Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Dr. Venteicher is part of a new translational research initiative between the University of Minnesota's Medical School and the Masonic Cancer Center that is exploring the genomics of brain tumors. His laboratory focuses on using new molecular techniques to understand how and why brain tumors develop and resist chemotherapy and radiation treatment. Translational research efforts such as these are of particular importance to identify new treatment options for patients with these diseases.